Flc Capital Advisors Merck & Co., Inc. Transaction History

Flc Capital Advisors

  • $396 Million
  • Q1 2024

A detailed history of Flc Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Flc Capital Advisors holds 84,603 shares of MRK stock, worth $10.5 Million. This represents 2.82% of its overall portfolio holdings.

Number of Shares
84,603
Previous 85,571 1.13%
Holding current value
$10.5 Million
Previous $9.33 Million 19.67%
% of portfolio
2.82%
Previous 2.52%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
SELL
$113.24 - $131.95 $109,616 - $127,727
-968 Reduced 1.13%
84,603 $11.2 Million
Q4 2023

Jan 18, 2024
BUY
$100.18 - $109.02 $270,185 - $294,026
2,697 Added 3.25%
85,571 $9.33 Million
Q3 2023

Jan 18, 2024
SELL
$102.95 - $114.33 $49,724 - $55,221
-483 Reduced 0.58%
82,874 $8.53 Million
Q1 2023

Apr 26, 2023
SELL
$102.94 - $114.86 $20,588 - $22,972
-200 Reduced 0.24%
83,357 $8.87 Million
Q4 2022

Jan 27, 2023
SELL
$87.44 - $112.11 $7,782 - $9,977
-89 Reduced 0.11%
83,557 $9.27 Million
Q3 2022

Oct 14, 2022
SELL
$84.53 - $94.96 $45,815 - $51,468
-542 Reduced 0.64%
83,646 $7.2 Million
Q2 2022

Jul 27, 2022
SELL
$83.49 - $94.64 $87,747 - $99,466
-1,051 Reduced 1.23%
84,188 $7.68 Million
Q1 2022

Apr 25, 2022
BUY
$73.51 - $82.4 $748,993 - $839,573
10,189 Added 13.58%
85,239 $6.99 Million
Q4 2021

Jan 26, 2022
BUY
$72.28 - $90.54 $106,757 - $133,727
1,477 Added 2.01%
75,050 $5.75 Million
Q3 2021

Oct 13, 2021
BUY
$71.68 - $78.83 $146,227 - $160,813
2,040 Added 2.85%
73,573 $5.53 Million
Q2 2021

Aug 12, 2021
BUY
$70.31 - $77.77 $82,614 - $91,379
1,175 Added 1.67%
71,533 $5.56 Million
Q1 2021

Apr 23, 2021
BUY
$68.86 - $81.11 $310,627 - $365,887
4,511 Added 6.85%
70,358 $5.42 Million
Q4 2020

Feb 10, 2021
BUY
$71.77 - $79.65 $239,065 - $265,314
3,331 Added 5.33%
65,847 $5.39 Million
Q3 2020

Oct 23, 2020
BUY
$73.18 - $82.95 $142,115 - $161,088
1,942 Added 3.21%
62,516 $4.89 Million
Q2 2020

Jul 10, 2020
BUY
$70.42 - $80.13 $227,597 - $258,980
3,232 Added 5.64%
60,574 $4.82 Million
Q1 2020

Apr 09, 2020
BUY
$63.36 - $87.82 $263,514 - $365,243
4,159 Added 7.82%
57,342 $4.41 Million
Q4 2019

Jan 13, 2020
SELL
$77.58 - $87.54 $71,761 - $80,974
-925 Reduced 1.71%
53,183 $4.84 Million
Q3 2019

Oct 29, 2019
SELL
$76.08 - $82.93 $91,296 - $99,516
-1,200 Reduced 2.17%
54,108 $4.56 Million
Q2 2019

Aug 05, 2019
SELL
$69.84 - $81.59 $13,269 - $15,502
-190 Reduced 0.34%
55,308 $4.65 Million
Q1 2019

May 13, 2019
BUY
$69.58 - $79.36 $153,910 - $175,544
2,212 Added 4.15%
55,498 $4.62 Million
Q4 2018

Feb 11, 2019
BUY
$65.24 - $75.71 $3.48 Million - $4.03 Million
53,286 New
53,286 $4.07 Million

Others Institutions Holding MRK

# of Institutions
3,766
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Flc Capital Advisors Portfolio

Follow Flc Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email